What is iMotions?
iMotions A/S operates at the intersection of neuroscience, psychology, and human-computer interaction. By developing a comprehensive, easy-to-use biometric research platform, the company enables researchers and commercial entities to capture, integrate, and analyze physiological data with unprecedented precision. Its software suite is instrumental in fields ranging from human factors engineering to business intelligence, allowing organizations to decode complex human responses in real-time.
The platform's ability to synthesize multi-modal data streams—such as eye-tracking, facial expression analysis, and galvanic skin response—positions iMotions as a foundational technology provider for the next generation of behavioral science and user experience research.
How much funding has iMotions raised?
iMotions has raised a total of $5.2M across 4 funding rounds:
Debt
$1.7M
Unspecified
$2.7M
Debt
$350K
Debt
$408K
Debt (2006): $1.7M, investors not publicly disclosed
Unspecified (2007): $2.7M, investors not publicly disclosed
Debt (2020): $350K supported by PPP
Debt (2021): $408K featuring PPP
Key Investors in iMotions
PPP
Public-Private Partnership
Undisclosed Investor
Undisclosed investor participating in the funding round.
Undisclosed Investor
Undisclosed investor participating in the funding round.
What's next for iMotions?
With this major enterprise-level funding, iMotions is well-positioned to accelerate its product roadmap and expand its footprint in the global neuroscience and behavioral research markets. The strategic allocation of this capital will likely focus on enhancing the scalability of its cloud-based infrastructure and deepening its integration capabilities with emerging hardware sensors.
As the demand for objective, data-driven insights into human behavior continues to rise across the healthcare, education, and corporate sectors, iMotions is poised to solidify its market leadership. The company's ongoing commitment to innovation at the MIT-based research hub suggests a continued focus on bridging the gap between academic rigor and commercial application, ensuring that its biometric platform remains the industry standard for high-stakes behavioral research.
